Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Analysis of age-related left ventricular collagen remodeling in living donors: Implications in arrhythmogenesis

  • García-Mendívil, Laura
  • Pérez-Zabalza, María
  • Mountris, Konstantinos
  • Duwé, Sam
  • Smisdom, Nick
  • Pérez, Marta
  • Luján, Lluis
  • Wolfs, Esther
  • Driesen, Ronald B.
  • Vallejo-Gil, José María
  • Fresneda-Roldán, Pedro Carlos
  • Fañanás-Mastral, Javier
  • Vázquez-Sancho, Manuel
  • Matamala-Adell, Marta
  • Sorribas-Berjón, Juan Fernando
  • Bellido-Morales, Javier André
  • Mancebón-Sierra, Francisco Javier
  • Vaca-Núñez, Alexander Sebastián
  • Ballester-Cuenca, Carlos
  • Oliván-Viguera, Aida
  • Diez, Emiliano
  • Ordovás, Laura
  • Pueyo, Esther
Age-related fibrosis in the left ventricle (LV) has been mainly studied in animals by assessing collagen content. Using second-harmonic generation microscopy and image processing, we evaluated amount, aggregation and spatial distribution of LV collagen in young to old pigs, and middle-age and elder living donors. All collagen features increased when comparing adult and old pigs with young ones, but not when comparing adult with old pigs or middle-age with elder individuals. Remarkably, all collagen parameters strongly correlated with lipofuscin, a biological age marker, in humans. By building patient-specific models of human ventricular tissue electrophysiology, we confirmed that amount and organization of fibrosis modulated arrhythmia vulnerability, and that distribution should be accounted for arrhythmia risk assessment. In conclusion, we characterize the age-associated changes in LV collagen and its potential implications for ventricular arrhythmia development. Consistency between pig and human results substantiate the pig as a relevant model of age-related LV collagen dynamics. © 2022 The Author(s)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Towards advanced cardiac miRNA therapies through DNA-based nanostructures

  • Hernandez-Bellido, N.
  • Postigo, A.
  • Orrite, C.
  • Garrido-Huescar, E.
  • Garcia-Mendivil, L.
  • Pueyo, E.
  • Hernandez-Ainsa, S.
  • Ordovas, L.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Interindividual Age-Independent Differences in Human CX43 Impact Ventricular Arrhythmic Risk

  • García-Mendívil, Laura
  • Pérez-Zabalza, María
  • Oliver-Gelabert, Antoni
  • Vallejo-Gil, José María
  • Fañanás-Mastral, Javier
  • Vázquez-Sancho, Manuel
  • Bellido-Morales, Javier André
  • Vaca-Núñez, Alexánder Sebastián
  • Ballester-Cuenca, Carlos
  • Diez, Emiliano
  • Ordovás, Laura
  • Pueyo, Esther
Connexin 43 (CX43) is one of the major components of gap junctions, the structures responsible for the intercellular communication and transmission of the electrical impulse in the left ventricle. There is limited information on the histological changes of CX43 with age and their effect on electrophysiology, especially in humans. Here, we analyzed left ventricular biopsies from living donors starting at midlife to characterize age-related CX43 remodeling. We assessed its quantity, degree of lateralization, and spatial heterogeneity together with fibrotic deposition. We observed no significant age-related remodeling of CX43. Only spatial heterogeneity increased slightly with age, and this increase was better explained by biological age than by chronological age. Importantly, we found that CX43 features varied considerably among individuals in our population with no relevant relationship to age or fibrosis content, in contrast to animal species. We used our experimental results to feed computational models of human ventricular electrophysiology and to assess the effects of interindividual differences in specific features of CX43 and fibrosis on conduction velocity, action potential duration, and arrhythmogenicity. We found that larger amounts of fibrosis were associated with the highest arrhythmic risk, with this risk being increased when fibrosis deposition was combined with a reduction in CX43 amount and/or with an increase in CX43 spatial heterogeneity. These mechanisms underlying high arrhythmic risk in some individuals were not associated with age in our study population. In conclusion, our data rule out CX43 remodeling as an age-related arrhythmic substrate in the population beyond midlife, but highlight its potential as a proarrhythmic factor at the individual level, especially when combined with increased fibrosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Assessing the influence of small structural modifications in simple DNA-based nanostructures on their role as drug nanocarriers

  • Postigo, Alejandro
  • Martínez-Vicente, Pablo
  • Baumann, Kevin N.
  • Barrio, Jesús del
  • Hernández-Ainsa, Silvia
DNA nanotechnology leverages Watson–Crick–Franklin base-pairing interactions to build complex DNA-based nanostructures (DNS). Due to DNA specific self-assembly properties, DNS can be designed with a total control of their architecture, which has been demonstrated to have an impact on the overall DNS features. Indeed, structural properties such as the shape, size and flexibility of DNS can influence their biostability as well as their ability to internalise into cells. We present here two series of simple DNS with small and precise variations related to their length or flexibility and study the influence that these structural changes have on their overall properties as drug nanocarriers. Results indicate that shorter and more flexible DNS present higher stability towards nuclease degradation. These structural changes also have a certain effect on their cell internalisation ability and drug release rate. Consequently, drug-loaded DNS cytotoxicity varies according to the design, with lower cell viability values obtained in the DNS exhibiting faster drug release and larger cell interaction rates. In summary, small changes in the structure of simple DNS can have an influence on their overall capabilities as drug nanocarriers. The effects reported here could guide the design of simple DNS for future therapeutic uses.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

DNA-Based Nanocarriers to Sequester Altered microRNAs in Cardiac Dysfunction

  • Postigo, Alejandro
  • Hernández-Bellido, Natalia
  • Sánchez-Barat, Marcos
  • García-Mendívil, Laura
  • Pueyo, Esther
  • del Barrio, Jesús
  • Hernández-Ainsa, Silvia
  • Ordovás, Laura
MicroRNAs (miRs) play a critical role in modulating gene expression across biological processes, including cardiac aging and disease. As such, miRs have demonstrated therapeutic potential in several cardiac conditions. Efficient delivery of miR therapies to cardiac tissue is crucial for effective gene therapy and DNA‐based nanocarriers (DNCs), based on Watson‐Crick‐Franklin highly specific base‐pair recognition, have emerged as a promising, biocompatible alternative to viral‐based methods. Here, DNCs designed to modulate miR levels as a potential treatment for cardiac dysfunction are presented. Specifically, the DNCs target miR‐24‐2, which inhibits SERCA2 gene. In humans, the reduction of SERCA2 activity is a hallmark of heart failure and is altered in cardiac aging. The assembled DNCs bearing anti‐miR‐24‐2‐5p sequences effectively restore intracellular levels of SERCA2 in a HEK293 cell model. The DNCs proper assembly is thoroughly verified, while their stability and miR‐capture ability are demonstrated in vitro. The DNCs exhibit successful internalization into HEK293 and modest uptake into human cardiomyocytes. SERCA2 restoration by DNCs is significantly influenced by the miR‐capture sequence layout, underscoring the importance of precise design for optimal biological outcomes. This study highlights the potential of DNCs in cardiac therapies, a previously unexplored avenue for addressing cardiac dysfunction.